The next annual Congress of the European Society of Cardiology was held in a hybrid format (onsite and online) from August 25 to 28, 2023 inAmsterdam (Netherlands). About 31,000 specialists from 150 countries took part in the event. Traditionally, the most anticipated events at the congress are the scientific HOT LINE sessions, where the results of the most important clinical trials are presented for the first time.clinical trials. This year, participants had the opportunity to learn about 29 specially selected randomised trials in 9 sessions over 4 days.
ADA Advises New BP, Lipid Targets for People With Diabetes New more aggressive targets for blood pressure and lipids are among the changes to the annual American Diabetes Association (ADA) Standards of Care in Diabetes — 2023. The document, long considered the gold standard for care of the more than 100 million Americans living with diabetes and prediabetes, was published December 12 as a supplement in Diabetes Care. The guidelines are also accessible to doctors via an app; last year's standards were accessed more than 4 million times.
American Heart Association (AHA) Scientific Sessions 2022 AHA’s Scientific Sessions 2022 in hybrid mode took place on Nov. 5-7, 2022, at McCormick Place Convention Center in Chicago, IL.
ESC Congress 2019 together with World Congress of Cardiology ESC Congress 2019 together with World Congress of Cardiology Saturday 31 August - Wednesday 4 September 2019 Paris - France
Announcement of the European Congress of Cardiology From August 31 to September 4, 2019, he Congress of the European Society of Cardiology in conjunction with the World Congress of Cardiology - will be held in Paris (France).
Trial Evaluating Sacubitril/Valsartan for HFpEF Misses Primary End Point Full detailed data from PARAGON-HF will be presented at the ESC Congress 2019 in September. Novartis announced topline results from the phase 3 PARAGON-HF study evaluating the safety and efficacy of sacubitril/valsartan (Entresto) in heart failure patients with preserved ejection fraction (HFpEF).
ESC Congress 2019 together with World Congress of Cardiology Full detailed data from PARAGON-HF will be presented at the ESC Congress 2019 in September. Novartis announced topline results from the phase 3 PARAGON-HF study evaluating the safety and efficacy of sacubitril/valsartan (Entresto) in heart failure patients with preserved ejection fraction (HFpEF).
Certain Social, Behavioral Factors Associated With Diabetes and Hypertension Onset Education and exercise may determine early start of diabetes and hypertension. Select behavioral and social risk factors were correlated with early onset of hypertension and diabetes, a prospective cohort study found. At 3.5 years of follow-up, among the patients without diabetes at baseline, 4% developed diabetes, while 6.4% of the cohort without baseline hypertension developed hypertension, reported Matthew Pantell, MD, MS, of the University of California, San Francisco, and colleagues.
THE FEATS OF DOCTORS DURING THE GREAT PATRIOTIC WAR (WORLD WAR II) During the war years, more than 700 thousand doctors and medical professionals worked at the front. At the end of the war, 12.5% of all these people were killed, and this figure seriously exceeds the losses in each individual military unit. But despite the danger, they never gave up, and in the most extreme situations only the iron will helped them to pull hundreds of people from the other world, and again to return to the battlefields. They achieved amazing results, and during the entire war, thanks to medical workers, about 72 percent of wounded soldiers and 90 percent of sick people, that is, approximately 17 million people, returned to the system.
The Congress for Cardiology and Internal medicine of Asian and CIS countries On April 26 - 27, 2019, the Congress for Cardiology and Internal medicine of Asian and CIS countries was held in Dushanbe (Tajikistan). The congress was organized by the Ministry of Health and Social Protection of Tajikistan and the Cardioprogress Foundation. In the opening ceremony, the Minister, Professor Olimzoda Nasim Khoja addressed the participants with greetings.
Stress-Related Disorders Increase CVD Risk Stress-related disorders may increase the risk for cardiovascular disease (CVD), especially during the first year after diagnosis, a large study shows.